Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities related to general business planning, including raising capital. It focuses on the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
8
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Aldeyra Therapeutics Inc market cap is $50.7M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Aldeyra Therapeutics Inc 52 week high is $5.93 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Aldeyra Therapeutics Inc 52 week low is $0.5271 as of November 21, 2026.
Aldeyra Therapeutics Inc stock price today is $0.84.
Aldeyra Therapeutics Inc stock price yesterday was $0.7217.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Aldeyra Therapeutics Inc's P/E ratio is -2.65.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Aldeyra Therapeutics Inc P/B ratio is 1.4394.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Aldeyra Therapeutics Inc 50-day moving average is $0.8953.